相关实验视频

Updated: Jan 20, 2026

Refined Murine Model of Idiopathic Pulmonary Fibrosis

Refined Murine Model of Idiopathic Pulmonary Fibrosis

Published on: June 17, 2025

针对异常性肺纤维化症的免疫机制和新疗法

Dongyang Gao¹, Wenli Gao², Zhiguang Zhai¹

¹Institute of Basic Theory for Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing, 100700, China.

Pharmaceutical science advances

|January 19, 2026

概括

异形性肺纤维化 (IPF) 涉及慢性肺炎和免疫系统功能障碍. 新兴的免疫调节药物为这种进展性纤维化肺部疾病提供了新的治疗途径.

科学领域:

免疫学免疫学免疫学
肺部医学肺部医学
药理学药理学是指药理学的学科.

背景情况:

异形性肺纤维化 (IPF) 是一种进展性肺部疾病,其特征是不可逆转的肺功能障碍.
纤维细胞增殖和过度的原沉积是慢性肺炎的结果.
虽然IPF的确切病原体尚不完全理解,但免疫机制越来越多地得到了认可.

研究的目的:

审查肺纤维化免疫病原性.
讨论IPF治疗的新兴免疫调节药物.
提供对IPF机制和未来治疗方向的见解.

主要方法:

关于IPF免疫病因的文献综述.
对IPF免疫调节药物开发的最新进展进行分析.
综合当前的理解和未来的前景.

主要成果:

人们越来越认识到先天性免疫,适应性免疫,免疫调节和细胞因子在IPF病变发生过程中的作用.
目前的IPF治疗方法有限,可能会导致不良反应.
了解免疫路径使得开发有针对性的免疫疗法成为可能.

结论:

准免疫系统对于新的IPF疗法具有前景.
对IPF免疫学的进一步研究可以指导开发更有效的治疗方法.
新兴的免疫调节药物代表了IPF管理中的潜在范式转变.

关键词:

免疫机制是免疫机制.新型治疗方法新型治疗方法肺部纤维化肺部纤维化治疗目标治疗目标

更多相关视频

Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo

Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo

Published on: May 5, 2023

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

Published on: May 9, 2025

相关概念视频

Refined Murine Model of Idiopathic Pulmonary Fibrosis

Refined Murine Model of Idiopathic Pulmonary Fibrosis

This protocol delineates a method for inducing pulmonary fibrosis in mice through repeated oropharyngeal administration of bleomycin, yielding pathological features closely resembling those of idiopathic pulmonary...

Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo

Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo

This protocol describes the isolation of pulmonary interstitial macrophages (IMs) and their adoptive transfer after IL-33 stimulation of the lung alveoli in a mouse model, which can facilitate the in vivo study of idiopathic pulmonary fibrosis...

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

This protocol demonstrates the oropharyngeal aspiration technique for use in the bleomycin murine model of pulmonary...

Establishment and Validation of a Rat Model of Pulmonary Arterial Hypertension Associated with Pulmonary Fibrosis

Establishment and Validation of a Rat Model of Pulmonary Arterial Hypertension Associated with Pulmonary Fibrosis

Here, the method of inducing pulmonary arterial hypertension associated with pulmonary fibrosis (PF-PH) rat model by injecting bleomycin into the airway is introduced. We also provide a step-by-step approach to validate this animal...

A Mouse Model of Pulmonary Fibrosis Induced by Nasal Bleomycin Nebulization

A Mouse Model of Pulmonary Fibrosis Induced by Nasal Bleomycin Nebulization

Various animal models of pulmonary fibrosis have been established using bleomycin to clarify the pathogenesis of pulmonary fibrosis and find new drug targets. However, most pulmonary fibrosis models targeting lung tissue have uneven drug administration. Here, we propose a model of uniform pulmonary fibrosis induced by nasal bleomycin...

Unilateral Lung Volume Analysis Using Micro-CT for Enhanced Assessment of Pulmonary Fibrosis in Preclinical Models

Unilateral Lung Volume Analysis Using Micro-CT for Enhanced Assessment of Pulmonary Fibrosis in Preclinical Models

Here, we present a protocol to utilize micro-computed tomography (micro-CT) to quantify ventilated regions in a unilateral bleomycin-induced pulmonary fibrosis model via intratracheal instillation on the lesional...